Failure to Monitor Resident After Narcan Administration
Summary
The facility failed to have a written policy to address the response to an opioid overdose and did not ensure that staff were trained and competent in monitoring a resident after the administration of Narcan medication. This deficiency was identified during the review of a case involving a resident who was administered Narcan for a suspected overdose. The staff did not provide continuous monitoring for potential recurrence of signs and symptoms of opioid toxicity for at least four hours after the administration of Narcan, as recommended by SAMHSA. The resident involved was a female with a history of substance abuse and several medical diagnoses, including schizoaffective disorder, bipolar disorder, and traumatic brain injury. On the day of the incident, the resident was found hard to arouse in her wheelchair, with normal vital signs but pinpoint pupils. Narcan was administered by an LPN, who noted that the resident became more responsive after the administration. However, the monitoring was insufficient, as the resident was not continuously observed for the recommended duration, and there was no documentation of a rapid drug test or further medical evaluation. Interviews with facility staff revealed inconsistencies in the understanding and execution of protocols for handling suspected overdoses. The LPN and RN involved in the incident did not conduct a rapid drug test, and there was no clear documentation of the monitoring process. The facility lacked a specific written policy for post-Narcan administration monitoring, and staff relied on their judgment without clear guidelines. The absence of a structured protocol and adequate training contributed to the deficiency in care provided to the resident.
Removal Plan
- R11 has been reassessed and shows no signs of active substance use.
- R11's care plan reviewed.
- All residents with a history of substance abuse have been reviewed by the Interdisciplinary Team for care plans and interventions.
- The facility has updated the substance use disorder policy to include post-Narcan administration monitoring, response to overdose, and when to indicate transfer.
- Nurses are being retrained and competencied on how to respond to emergencies related to substance use including administration and monitoring after giving Naloxone, administering Cardiopulmonary Resuscitation when appropriate, and hospital transfer. Nurses on vacation or Family Medical Leave will be inserviced and competencied before returning to work. New Nurses will be inserviced and competencied during New Employee Orientation, prior to working directly with residents. Agency Nurses will be provided inservice material in their Orientation Packet that they receive prior to their first scheduled shift.
- A Quality Assurance Performance Improvement meeting was held with the medical director to discuss the incident with R11, policy updates, and follow up.
- During the monthly Quality Assurance Meeting, Interdisciplinary Team will review ongoing training of nurses, review competencies and review any incidents of Narcan medication administration.
- The facility will monitor the next 5 uses of Narcan to ensure staff follow the updated facility policy on substance use.
- The facility will randomly competency 3 nurses a week for the next 12 weeks to ensure they are aware of the proper protocol for Narcan administration and substance use. Competencies will be added to Annual Nursing Competencies.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.